Warfarin—Is Self-Care the Best Care?-Reference-Cited by-同舟云学术

Warfarin—Is Self-Care the Best Care?

Published:2022-02-08 Issue:04 Volume:122 Page:471-474
ISSN:0340-6245
Container-title:Thrombosis and Haemostasis
language:en
Short-container-title:Thromb Haemost

Author:

Ritchie Leona A.¹²,Penson Peter E.¹³^ORCID,Lane Deirdre A.¹²⁴^ORCID

Affiliation:

1. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom

2. Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom

3. School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom

4. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

Publisher

Georg Thieme Verlag KG

Subject

Hematology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0042-1742363.pdf

Reference19 articles.

1. Lower versus standard INR targets in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials;A K Pandey;Thromb Haemost,2020

2. Quality of vitamin K antagonist control and 1-year outcomes in patients with atrial fibrillation: a global perspective from the GARFIELD-AF registry;S Haas;PLoS One,2016

3. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review;Y Wan;Circ Cardiovasc Qual Outcomes,2008

4. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC;G Hindricks;Eur Heart J,2021

5. 2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: executive summary;T F Chao;Thromb Haemost,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing anticoagulant therapy: is pharmacist-led intervention the best;European Heart Journal - Quality of Care and Clinical Outcomes;2024-06-14

2. Multistage Anticoagulant Surfaces: A Synergistic Combination of Protein Resistance, Fibrinolysis, and Endothelialization;ACS Applied Materials & Interfaces;2023-07-19

3. Lessons learned from the influence of CYP2C9 genotype on warfarin dosing;Expert Opinion on Drug Metabolism & Toxicology;2023-04-03